Alfacell Provides Update on ONCONASE(R) Malignant Mesothelioma Phase IIIb Trial
Alfacell Corporation today provided an update on the status of its international, confirmatory Phase IIIb malignant mesothelioma trial for ONCONASE� , the Company's lead investigational drug candidate:
In scholarships, sweat the small stuff
Those smaller awards can really add up, and there's less competition for them.
Death rate from rare cancer 9.5 times higher near plant
OSAKA (Kyodo) The risk of dying from mesothelioma, a rare type of cancer linked to asbestos, is 9.5 times higher than the national average among people who lived within 500 meters of a now-defunct Kubota Corp. asbestos plant in Amagasaki, Hyogo Prefecture, a professor said Saturday.
Japanese editorial excerpts -4-
_ Selected editorial excerpts from the Japanese press:
"An Environmental Time Bomb" In Japan
Tokyo ignored asbestos for years. For decades asbestos has been known to cause cancer in those who inhale its tiny fibers. That has triggered restrictions on its use and, ultimately, thousands of lawsuits in the U.S. and elsewhere.
Asbestos fears deepen in Japan with reports of widespread household use
Health fears over asbestos deepened in Japan as a news report revealed that one in five houses uses roofing tiles containing the material.
LEAD: FY 2006 general-account budget to total 85 tril. yen
_ (EDS: ADDING MORE INFO)
News In Brief
By Geoff Fox AN engineer who was suing Yorkshire Water for hundreds of thousands of pounds for th... By Paul Robinson A MULTIPLE pile-up on the M62 in West Yorkshire killed a woman, left a man fight...
Millions of homes have asbestos roofing
OSAKA (Kyodo) Roofing tiles used in up to 5 million homes in Japan -- 20 percent of the total -- are believed to contain asbestos, tile makers said Saturday.
Roofing tiles in 5 million houses may contain asbestos
_ Roofing tiles used in up to 5 million or 20 percent of houses in Japan are believed to contain asbestos, tile makers said Saturday, a new discovery implying further threats to people's health.
No comments:
Post a Comment